PubMed چکیده/رکورد

Apelin-driven metabolic ratios reflect post-stroke recovery in mice.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Visceral fat gain and the progressive onset of metabolic disorders precipitate stroke risk and prompt the middle-aged population to cognitive decline. Preclinical research has recently focused on total apelin, a neuroprotective peptide whose cerebral action after release in plasma by adipose tissue remains elusive. The ratio between plasma apelin and lipids is suspected to influence prognosis in patients with cardiovascular diseases. This study challenged ratios of plasma apelin to cholesterol or glucose in reflecting post-stroke recovery of mature adult mice after a 6-month high-fat diet (HFD). Mice under HFD developed overweight (+10%, p < 0.001), hyperglycemia (21%, p < 0.001) and hypercholesterolemia (+68%, p < 0.001). Plasma apelin decreased with age in all mice (F2,360 = 35.94, p < 0.001), but a 30-min middle cerebral artery occlusion (MCAO) induced a 27% drop in plasma apelin (p < 0.01) in HFD-fed mice only, as well as a higher acute mortality (29%) than in normal diet (ND)-fed mice (19%). Ten days after MCAO, apelin levels normalized in HFD-fed mice, but were still decreasing in ND-fed mice (p < 0.01). However, high pre-stroke ratios revealed an upregulation of brain apelin receptor expression in these mice, that was lost in metabolically disturbed mice displaying lower ratios. This was functionally confirmed since mice with higher pre-stroke ratios displayed significantly better locomotor and cognitive performances, as validated by ROC analysis (AUC = 0.85). This study highlights pre-stroke ratios of plasma apelin to cholesterol or glucose as potential new biomarkers of post-stroke recovery.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

ApelinMetabolic disordersMiceStroke
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Intestinal gases as markers to study the diet-gut microbiota-host metabolism axis in humans and their relationship to metabolic health.

The gut microbiota‒host metabolism axis is a critical determinant of metabolic health, yet its functional activity remains difficult to monitor in vivo. The gut microbiota ferments undigested food components such as dietary fibers and proteins, yielding various important metabolites and gases that impact human metabolism. This review synthesizes current evidence on intestinal gases, primarily hydrogen (H2), methane (CH4) and hydrogen s…

PubMed2026

The onset of hypertension in metabolic syndrome is independent of renal sympathetic innervation.

Increased sympathetic tone and hypertension are hallmarks of metabolic syndrome and contribute to chronic kidney disease. Although renal sympathetic denervation transiently lowers blood pressure, its role in the development of metabolic and renal alterations remains unclear. Here, we evaluated the contribution of renal sympathetic input to the onset and progression of high-fat diet-induced alterations. Male Wistar rats underwent bilate…

PubMed2026

Lactiplantibacillus plantarum WJL ameliorates chronic kidney disease by inhibiting fibroblast growth factor 21 adaptive stress response via low protein diet.

Low-protein diets (LPD) are recommended in chronic kidney disease (CKD) to reduce disease progression. However, their clinical efficacy and safety are debated due to the risk of protein-energy wasting. A deeper mechanistic understanding is therefore required. Herein, the metabolic effects of LPD in both murine models and a randomized controlled trial in nondiabetic CKD patients were investigated, focusing on glucose homeostasis, plasma…

PubMed2026

Christensenella massiliensis reduces kynurenine levels and alleviates obesity and related metabolic disorders in model mice.

Next-generation probiotics derived from gut commensals show promise for metabolic disease intervention, yet effective anti-obesity strains remain limited. Here, we demonstrate that oral administration of Christensenella massiliensis markedly alleviates obesity and metabolic dysfunction in high-fat diet-induced obese mice. Treatment reduced food intake, improved glucose tolerance and insulin sensitivity, lowered blood glucose and lipid …